| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/05/2009 | CA2537402C Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2403352C Use of comt inhibitors as analgesics |
| 05/05/2009 | CA2345521C Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 05/05/2009 | CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 05/05/2009 | CA2166394C Improved nicotine lozenge and therapeutic method for smoking cessation |
| 04/30/2009 | WO2009055828A1 New tetracyclic compounds |
| 04/30/2009 | WO2009055734A1 Condensed compounds with activity at estrogen receptors |
| 04/30/2009 | WO2009055671A1 Compositions and methods for treating cystic fibrosis |
| 04/30/2009 | WO2009055548A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009055308A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/30/2009 | WO2009054994A2 Use of compounds activating sirt-3 for mimicking exercise |
| 04/30/2009 | WO2009054984A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | WO2009054923A2 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist |
| 04/30/2009 | WO2009054793A1 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054792A1 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054791A1 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054790A1 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054789A1 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054787A1 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054786A1 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054544A1 Ampa receptor antagonists for parkinson's disease and movement disorders |
| 04/30/2009 | WO2009054543A1 Ampa receptor antagonists and zonisamide for parkinson's disease and movement disorders |
| 04/30/2009 | WO2009054537A1 PEPTIDE VACCINE USING MIMIC MOLECULE OF AMYLOID β-PEPTIDE |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054128A1 Method for efficient production of monocyte-derived multipotent cell (momc) |
| 04/30/2009 | WO2009053997A1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| 04/30/2009 | WO2009053799A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/30/2009 | WO2009053731A1 Process for preparing o-desmethylvenlafaxine |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009053697A1 Polymorphic forms of ( s ) -rotigotine hydrochloride |
| 04/30/2009 | WO2009053696A1 Monoclonal antibody for app |
| 04/30/2009 | WO2009053628A2 Novel compounds, preparation and uses thereof |
| 04/30/2009 | WO2009053553A1 Rimonabant 2-methoxyethanol solvate and method for preparing same |
| 04/30/2009 | WO2009053552A1 Rimonabant methanol solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053550A1 Rimonabant n-methylpyrrolidone solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053549A1 Rimonabant dmso solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053548A1 Rimonabant 1,4-dioxane solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053536A2 Splice variants of gdnf and uses thereof |
| 04/30/2009 | WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
| 04/30/2009 | WO2009053449A1 Thiazoles which potentiate ampa receptor and medicinal uses thereof |
| 04/30/2009 | WO2009053448A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 04/30/2009 | WO2009053444A1 Compounds of 2,3-dihydro-benzofuran |
| 04/30/2009 | WO2009053443A2 Indane compounds |
| 04/30/2009 | WO2009053441A1 Phenylpyrrolidine compounds |
| 04/30/2009 | WO2009053440A1 Indoline compounds |
| 04/30/2009 | WO2009053373A1 Quinolinone derivatives as parp inhibitors |
| 04/30/2009 | WO2009053098A1 Inhibitors of caspase i-dependent cytokines in the treatment of neurodegenerative disorders |
| 04/30/2009 | WO2009053070A1 Compounds for treating demyelination conditions |
| 04/30/2009 | WO2009052895A1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| 04/30/2009 | WO2009052737A1 Medicament for preventing and controlling alzheimer's disease |
| 04/30/2009 | WO2009052591A1 Method of treatment with potentised stereoisomer of glutamate |
| 04/30/2009 | WO2009039362A3 Chiral synthesis of diazepinoquinolines |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009025839A3 Phosphodiesterase 10 inhibitors |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2008140545A3 Inhibiting smad signaling promotes neuron regeneration |
| 04/30/2009 | WO2008140421A3 Heterocycloalkyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008140420A3 Pyrimidine derivatives |
| 04/30/2009 | WO2008140419A3 Pyridyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008138605A3 Method for producing n-methylnaltrexone bromide |
| 04/30/2009 | WO2008116226A8 Magnesium compositions and uses thereof |
| 04/30/2009 | WO2008073779A3 Compositions and methods for treating seizures |
| 04/30/2009 | WO2008061209A3 G protein coupled receptors and uses thereof |
| 04/30/2009 | WO2008027357A9 Pharmaceutical compositions of clonazepam and methods of use thereof |
| 04/30/2009 | WO2008017000A8 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | WO2005102389A9 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111992 Alkyl ether derivatives or salts thereof |
| 04/30/2009 | US20090111874 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 04/30/2009 | US20090111872 Stabilized pediatric suspension of carisbamate |
| 04/30/2009 | US20090111865 Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof |
| 04/30/2009 | US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| 04/30/2009 | US20090111858 Novel Alpha-(N-Sulfonamido)Acetamide Compound as an Inhibitor of Beta Amyloid Peptide Production |
| 04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111846 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders |
| 04/30/2009 | US20090111842 Spirocyclic cyclohexane compounds with analgesic activity |
| 04/30/2009 | US20090111841 Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 04/30/2009 | US20090111838 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/30/2009 | US20090111837 Use of pde7 inhibitors for the treatment of neuropathic pain |
| 04/30/2009 | US20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 04/30/2009 | US20090111830 7-Chloro-2-[(4,4-difluorocyclohexyl)methyl]-1-oxoisoindoline-5-carbonitrile, used for the treatment of schizophrenia |
| 04/30/2009 | US20090111829 Aripiprazole Salts |
| 04/30/2009 | US20090111827 ARYLINDENOPYRIMIDINES COMPOUND AND USE AS AN ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111813 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/30/2009 | US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111810 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | US20090111801 Substituted pyrazinone derivatives for use as a medicine |
| 04/30/2009 | US20090111797 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches |
| 04/30/2009 | US20090111793 Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production |
| 04/30/2009 | US20090111792 Injectable capsaicin with tricyclic antidepressant adjunctive agent |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |